Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

The Use of FDG PET for Nodal Staging of Non-Small-Cell Lung Cancer

비소세포폐암 환자의 국소 림프절 전이 발견을 위한 FDG PET의 이용

  • Published : 1999.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Positron emission tomography(PEFT) using fluorine-18 deoxyglucose(FDG), showing increased FDG uptake and retention in malignant cells, has been proven to be useful in differentiating malignant from benign tissues. We indertook the prospective study to compare the accuracy of the whole-body FDG PET with that of the conventional chest computed tomography(CT) for nodal staging of non-small-cell lung cancers(NSCLC). Material and Method: FDG PET and contrast enhanced CT were performed in 36 patients with potentially resectable NSCLC. Each Imaging study was evaluated independently, and nodal stations were localized according to the AJCC regional lymph nodes mapping system. Extensive lymph node dissection(1101 nodes) of ipsi- and contralateral mediastinal nodal stations was performed at thoracotomy and/or mediastinoscopy. Image findings were compared with the histopathologic staging results and were analyzed with the McNema test(p) and Kappa value(k). Result: The sensitivity, specificity, positive predictive value, and negative predictive value of CT for ipsilateral mediastinal nodal staging were 38%, 68%, 25%, 79%, and 61%, and those of PET were 88%, 71%, 47%, 95%, and 75%(p>0.05, K=0.29). When analyzed by individual nodal group(superior, aortopulmonary window, and inferior), the sensitivity, specificity, positive predictive value, and negative predictive value of CT were 27%, 82%, 22%, 85%, and 73%, and those of PET were 60%, 87%, 92%, and 82%(p<0.05, k=0.27). Conclusion: FDG PET in addition to CT appears to be superior to CT alone for mediastinal staging of non-small cell lung cancers.

Keywords

References

  1. Radiology v.178 CT and MRI imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group Webb WR;Gatsonis C;Zerhouni EA(et al.)
  2. 대한방사선과학회지 v.38 CT를 이용한 폐암의 종격동 림프절 전이 여부의 평가에 영향을 미치는 요인들 최두환;이태현;김기환;진수일;조재일;조경자
  3. J Thorac Cardiocasc Srug v.104 Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinonia Izbicki JR;Thetter O;Kreusser T(et al.)
  4. Radiology v.188 Focal pulmonary abnormalities evaluation with F-18 flnorodeoxyglucose PET scanning Patz EF;Lowe VL;Hoffman JM(et al.)
  5. Radiology v.188 Positron emission tomogfaphy of lung cancers and medrastinal lymph nodes using 18=F fluorodeoxyglncose Scott WJ;Schwave JL;Gupta NC(et al.)
  6. Radiology v.191 Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation Whal RL;Quint LE;Greenough RL;Meyer CR;White RI;Orringer MB
  7. Chest v.107 Detection of scalene lymph node metastases from lung cancer. position emssion tomography Scott WJ;Gobat LS;Hausen LG(et al.)
  8. Eur J Nucl Med v.23 The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography Sasaki M;Ichyya Y;Kuwabara Y(et al.)
  9. Radiology v.202 Non-small cell lung cancer Nodal staging with FDG PET versus CT with corerelative lymph node mapping and sampling Steinert HC;Hausei M;Allemann E(et al.)
  10. Ann Thorac Surg v.60 Staging non-small cell lung cancer by whole body posuron emissiontomographic imaging Valk PE;Pounds TR;Hopkins DM(et al.)
  11. Ann Thorac Surg v.65 Posirron emission tomography in lung cancer Lowe VJ;Naunheim KS
  12. J Thorac Cardiovasc Surg v.11 Mediastinal lymph node staging of non-small cell lung cancer: a prospective comparison of computed tomography and positron emission tomography Scott WJ;Gobar LS;Terry JD(et al.)
  13. Eur J Nucl Med v.23 Staging of non-small cell lung cancer by whole-body fluorine-18 deoxyglucose positron emssion tomography Bury T;Dowlati A;Paulus P(et al.)
  14. Eur J Nucl Med v.25 Fluorine-18 deoxyglucose position emission tomography for the detection of bone metastases in patients with non-small cell lung cancer Bury T;Batreto A;Daeuen F(et al.)
  15. General rule for clinical and pathological record of lung cancer(4th ed.) The Japn Lung Cancer Society
  16. Basic and Clinical Biastatisties Dawson-Saunders;Trapp RG
  17. Radiology v.178 Machinaking and McNemar in the comparison of diagnostic modalities Dwyer AJ
  18. Statistical methods for rates and proportions(2nd ed.) Fless JL
  19. Am Rev Respir Dis v.144 Does the mediastinum of patients with non-small lung cancer reauire histologic staging? Malenka DJ;Colice GL;Beck JR
  20. J Nucl Med v.37 Decision tree sensitivity analysis for cost-effectiveness of FDG PET in staging and management of non-small cell nung carcinoma Gambhir SS;Hob CK;PHelps ME(et al.)